EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

The Effect of COVID-19 Vaccination on the Risk of Persistent Post–COVID-19 Condition: Cohort Study

Pontus Hedberg iD, Suzanne Desirée van der Werff iD, Pontus Nauclér

The Journal of Infectious Diseases · 02.06.2025 · 231 (5) · e941-e944

DOI: 10.1093/infdis/jiaf133 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 12.03.2025. Verfasst von Pontus Hedberg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Vaccination. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We conducted a population-based cohort study in Stockholm, Sweden, to investigate the effect of COVID-19 vaccination on the risk of developing persistent post–COVID-19 condition (PCC) in individuals surviving the first year after a SARS-CoV-2 infection. In total, 331 042 individuals were included, of which 852 had persistent PCC. The adjusted risk ratio for developing persistent PCC compared with unvaccinated individuals was 0.81 (95% confidence interval [CI], .59–1.10) for 1 dose, 0.42 (95% CI, .35–.52) for 2 doses, and 0.37 (95% CI, .27–.52) for 3 doses. Reduced risks for vaccinated individuals were also observed when restricting the analyses to pre-Omicron and Omicron, as well as all subgroups including sex, age, and previous infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesVaccinationHumansMaleFemaleMiddle AgedSwedenAdultAgedSARS-CoV-2Cohort StudiesYoung AdultAdolescentRisk FactorsAged, 80 and over

Stichwörter der Autor:innen

COVID-19SARS-CoV-2Vaccinationlong COVIDpost–COVID-19 condition

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Division of Infectious Diseases, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

ORCID-Profile: Pontus Hedberg, Suzanne Desirée van der Werff

Förderung

  • Swedish Research Council
  • European Union

Zitieren

APA

Hedberg, P., van der Werff, S. D., & Nauclér, P. (2025). The Effect of COVID-19 Vaccination on the Risk of Persistent Post–COVID-19 Condition: Cohort Study. The Journal of Infectious Diseases, 231(5), e941-e944. https://doi.org/10.1093/infdis/jiaf133

Vancouver

Hedberg P, van der Werff SD, Nauclér P. The Effect of COVID-19 Vaccination on the Risk of Persistent Post–COVID-19 Condition: Cohort Study. The Journal of Infectious Diseases. 2025;231(5):e941-e944. doi:10.1093/infdis/jiaf133

BibTeX
@article{Hedberg2025,
  author = {Hedberg, Pontus and van der Werff, Suzanne Desirée and Nauclér, Pontus},
  title = {The Effect of COVID-19 Vaccination on the Risk of Persistent Post–COVID-19 Condition: Cohort Study},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  volume = {231},
  number = {5},
  pages = {e941--e944},
  doi = {10.1093/infdis/jiaf133}
}
Kostenlos starten →